TNF therapy does not raise cancer risk in RA patients; overall cancer risk comparable to those not taking immunosuppressive drugs

29. October 2009 01:00

A recent study by Swedish researchers found that rheumatoid arthritis (RA) patients did not experience an elevated cancer risk in the first 6 years after starting anti-tumor necrosis factor (TNF) therapy. [More]

28e18ce0-6676-427e-878b-b09908a3250b|0|.0

Posted in: Medical Condition News | Pharmaceutical News

Tags: Adalimumab, Arthritis, Autoimmune Disease, Cancer, Etanercept, Hospital, Infliximab, Methotrexate, Rheumatism, Rheumatoid Arthritis, Rheumatology, TNF Blockers

New data from CIMZIA WELCOME trial to be presented at the ACG meeting

28. October 2009 08:22

According to new results from the WELCOME trial, exploratory data analyzing the impact of treatment with CIMZIA(®) (certolizumab pegol) - the only PEGylated anti-TNF (alpha) (Tumor Necrosis Factor alpha) - administered either every two weeks or every four weeks, showed that the majority of Crohn's disease patients in both dosing groups experienced no hospitalizations and surgical procedures during the course of the 26-week study. [More]

dc4421a5-6474-4f57-8556-7aab68f3c0ca|0|.0

Posted in: Drug Trial News | Medical Condition News

Tags: Abatacept, Anemia, Angioedema, Antibody, Arthralgia, Arthritis, Autoimmune Disease, Cancer, Congestive Heart Failure, Crohn's Disease, Dyspnea, Exercise, Gastroenterology, Headache, Heart Failure, Hepatitis B, Hospital, Hypersensitivity, Immunology, Inflammatory Bowel Disease, Infliximab, Leukopenia, Listeriosis, Lupus, Lymphoma, Melanoma, Methotrexate, Nausea, Nervous System, Neuropathy, Rheumatoid Arthritis, Rituximab, Sepsis, Skin Cancer, Thrombocytopenia, TNF Blockers, Tuberculosis, Ulcerative Colitis, Urticaria, Virus, Vomiting

Report on the future market potential for monoclonal antibodies

27. October 2009 08:28

Reportlinker Adds Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment [More]

1390c2ed-5424-4638-98ae-15d3991e0ba3|0|.0

Posted in: Pharmaceutical News

Tags: Adalimumab, Alzheimer's Disease, Antibody, Arthritis, Avastin, Bevacizumab, Biotechnology, Cancer, Cetuximab, Crohn's Disease, Eculizumab, Evolution, Genetics, Hodgkin's Lymphoma, Infliximab, Lymphoma, Macular Degeneration, Monoclonal Antibody, Multiple Sclerosis, Non-Hodgkin's Lymphoma, Psoriasis, Ranibizumab, Raptiva, Rheumatoid Arthritis, Rituximab, Transplant, Vectibix, Zevalin

New data on Phase 3 SIMPONI clinical trials for rheumatoid arthritis

19. October 2009 09:41

New long-term data from two pivotal, Phase 3 clinical trials showed that patients with active rheumatoid arthritis (RA) receiving SIMPONI(TM) (golimumab) every four weeks achieved sustained improvements in signs and symptoms and physical function response through one year. These new data were presented today at the 2009 American College of Rheumatology (ACR) Annual Scientific Meeting. [More]

c732a27a-bf6d-438e-85d8-c315df6be186|0|.0

Posted in: Drug Trial News | Medical Condition News

Tags: Adalimumab, Ankylosing Spondylitis, Antibody, Arthritis, Blood Pressure, Breast Cancer, Bronchitis, Cancer, Cartilage, Cell, Cold Sores, Cough, Diabetes, Diarrhea, Education, Etanercept, Golimumab, Heart Failure, Hepatitis B, Hygiene, Immunology, Infliximab, Lupus, Lymphoma, Methotrexate, Monoclonal Antibody, Multiple Sclerosis, Nausea, Nephrology, Nervous System, Oncology, Psoriatic Arthritis, Rheumatoid Arthritis, Rheumatology, TNF Blockers, Tuberculosis, Vaccine, Virus, Vomiting, Weight Loss

Johnson & Johnson announces financial results for the third quarter of 2009

13. October 2009 08:07

Johnson & Johnson today announced sales of $15.1 billion for the third quarter of 2009, a decrease of 5.3% as compared to the third quarter of 2008. Operational results declined 2.8% and the negative impact of currency was 2.5%. Domestic sales declined 8.1%, while international sales declined 2.5%, reflecting operational growth of 2.4% and a negative currency impact of 4.9%. [More]

8c6ce202-17d8-44a3-89cc-c43686b2d777|0|.0

Posted in: Business / Finance

Tags: Ankylosing Spondylitis, Antipsychotic, Arthritis, Diabetes, Emtricitabine, Fentanyl, Golimumab, Immunotherapy, Infliximab, Influenza, Investment, Migraine, Multiple Myeloma, New Drug Application, Paliperidone Palmitate, Psoriasis, Psoriatic Arthritis, Reminyl, Rheumatoid Arthritis, Schizophrenia, Spine, Sports Medicine, Stent, Tenofovir, Truvada

More studies needed to compare the efficacy of different biologic drugs for RA, say researchers

7. October 2009 04:34

More studies that directly compare the effectiveness of different biologic drugs for rheumatoid arthritis (RA) are needed, say Cochrane Researchers. The researchers reviewed all previous Cochrane Systematic Reviews assessing the effectiveness of biologic disease-modifying drugs for treatment of RA and found that although all were very effective, there was little data on direct comparisons between the drugs that could help doctors decide which to prescribe. [More]

17550acc-8d66-47bd-94f2-3bde9f5e4c7d|0|.0

Posted in: Medical Condition News

Tags: Abatacept, Adalimumab, Arthritis, Autoimmune Disease, Etanercept, Infliximab, Methotrexate, Rheumatoid Arthritis, Rituximab, Veterans Affairs

Mayo study reveals infliximab reduces the need for colectomy

1. October 2009 09:39

A new study led by Mayo Clinic researchers has found that ulcerative colitis patients had a 41 percent reduction in colectomy after a year when treated with infliximab, according to a study published in the October 2009 issue of Gastroenterology. [More]

685781af-9a67-4d6b-9a7a-a23954e202fa|0|.0

Posted in: Medical Condition News | Pharmaceutical News

Tags: Abdominal Pain, Antibody, Cell, Crohn's Disease, Diarrhea, Education, Gastroenterology, Hepatology, Inflammatory Bowel Disease, Infliximab, Ulcerative Colitis

Reportlinker's medical review criteria guidelines for managing care

30. September 2009 08:03

Reportlinker Adds Medical Review Criteria Guidelines for Managing Care (8th ed. - 2009) [More]

8df1ed87-8391-4b34-bf59-57c82f4b06c0|0|.0

Posted in: Healthcare News

Tags: Acne, Acupuncture, Allergy, Alopecia, Alternative Medicine, Analgesia, Anesthesiology, Angina, Angioplasty, Antibody, Aortic Aneurysm, Appendectomy, Asthma, Atopic Dermatitis, Atrial Fibrillation, Autism, Back Pain, Balloon Angioplasty, Bariatric Surgery, Barrett's Esophagus, Basal Cell Carcinoma, Biopsy, Blood Pressure, Bone, Bone Marrow, Brachytherapy, Brain, Breast Cancer, Burn, Calcium, Cancer, Cardiology, Cardiomyopathy, Cartilage, Catheter, Catheter Ablation, Celiac Disease, Cell, Cellulitis, Cerebral Palsy, Chemotherapy, Cholesterol, Cleft Palate, Collagen, Colon Cancer, Colonoscopy, Colorectal Cancer, Congestive Heart Failure, Coronary Artery Disease, Cystic Fibrosis, Cytology, Dandruff, Defibrillator, Dendritic Cell, Dermatitis, Dermatology, Diabetes, Diabetes Mellitus, Diabetic Neuropathy, Dialysis, Diet, DNA, Dysplasia, Dystonia, Education, Epidural, Etanercept, Exercise, Fibrosis, Gastroenterology, Gene Expression, Gonadotropin, Headache, Hearing Loss, Heart Failure, Hematology, Hemophilia, Hepatitis B, Herpes, Herpes Zoster, Histamine, Homeopathy, Hospital, Hypersensitivity, Hypoglycemia, Hypothermia, Immunization, Immunotherapy, Impetigo, Implants, Incontinence, Inflammatory Bowel Disease, Infliximab, Influenza, Insulin, Interleukin-2, Kinesiology, Light Therapy, Lung Cancer, Lyme Disease, Lymphedema, Macrophage, Mastectomy, Medicare, Meditation, Melanoma, Meniere's Disease, Metastasis, Microscopy, Migraine, Monoclonal Antibody, Mozobil, Nephrology, Nervous System, Neuralgia, Neuroimaging, Neurology, Neuropathy, Neurosurgery, Nuclear Medicine, Nursing, Nutrition, Obesity, Obstructive Sleep Apnea, Oncology, Osteoarthritis, Osteonecrosis, Otitis Media, Ovarian Cancer, Oxygen Therapy, Palliative Care, Paralysis, Photodynamic Therapy, Plastic Surgery, Prosthetic, Psoriasis, Radiofrequency Ablation, Renal Failure, Rhinitis, Rosacea, Scabies, Schizophrenia, Scleroderma, Scoliosis, Sexual Dysfunction, Sigmoidoscopy, Sinusitis, Sleep, Sleep Apnea, Smoking, Smoking Cessation, Speech, Squamous Cell Carcinoma, Stem Cell, Stenosis, Stent, Stress, Stroke, Tinnitus, Tonsillectomy, Transplant, Ultrasound, Urinary Incontinence, Ventilator, Vitiligo, Wound Healing, Yoga

Comprehensive and practical overview of psoriasis

22. September 2009 06:00

Treatments for psoriasis often present a therapeutic challenge to physicians because, besides affecting the skin, psoriasis may be associated with various comorbidities (for instance, depression, psoriatic arthritis, Crohn's disease and, in severe psoriasis, metabolic syndrome and cardiovascular diseases). [More]

d07b8d35-fc50-4e9e-802e-9086d402e363|0|.0

Posted in: Medical Condition News

Tags: Adalimumab, Arthritis, Crohn's Disease, Cyclosporine, Depression, Etanercept, Infliximab, Metabolic Syndrome, Methotrexate, Psoriasis, Psoriatic Arthritis

Report on autoimmune disease therapeutics in worldwide markets

9. September 2009 04:08

Reportlinker.com announces that a new market research report is available in its catalogue. Autoimmune Disease Therapeutics [More]

a05922ef-ab5b-4527-9eba-45129dafaf55|0|.0

Posted in: Medical Condition News

Tags: Ankylosing Spondylitis, Antibody, Arthritis, Autoimmune Disease, Avonex, Cancer, Crohn's Disease, Diabetes, Diabetes Mellitus, Infliximab, Insulin, Lupus, Monoclonal Antibody, Multiple Sclerosis, Pathology, Pfizer, Psoriasis, Raptiva, Rheumatoid Arthritis, Rituximab, Scleroderma, Sjogren's Syndrome, Systemic Lupus Erythematosus, Transplant, Type 1 Diabetes, Ulcerative Colitis, Vasculitis

New report on the psoriasis market offered by Research and Markets

4. September 2009 05:15

Research and Markets (http://www.researchandmarkets.com/research/b8d445/commercial_insight) has announced the addition of the "Commercial Insight: Psoriasis - Intellectual property drives growth" report to their offering. [More]

e6337cbf-a1d1-44e4-8922-4a86a1ba61b8|0|.0

Posted in: Medical Condition News

Tags: Adalimumab, Arthritis, Calcitriol, Corticosteroid, Dermatology, Etanercept, Infliximab, Psoriasis, Raptiva, Rheumatoid Arthritis, Tuberculosis

Golimumab shows promise for rheumatoid arthritis

28. June 2009 21:37

Golimumab, a new tumour necrosis factor-α (TNF-α) inhibitor reduces the signs and symptoms of rheumatoid arthritis in patients who have previously received any other TNF-α inhibitor, and might be a good option for patients who have inadequate responses to one or two other TNF-α inhibitors, finds an Article published Online first and in this week's edition of The Lancet. [More]

fb1c8293-a954-4911-b630-e9164cf1e9e0|2|5.0

Posted in: Drug Trial News

Tags: Adalimumab, Etanercept, Golimumab, Infliximab, Rheumatoid Arthritis, TNF Blockers

Impact of Medicare Part D on access to and cost sharing for specialty biologic medications for beneficiaries with rheumatoid arthritis

1. June 2009 19:33

Biologic disease-modifying antirheumatic drugs (DMARDs) such as adalimumab, etanercept and infliximab are effective at reducing symptoms and slowing progression of rheumatoid arthritis (RA). These drugs act more quickly, require less laboratory monitoring, and are better tolerated than nonbiologic DMARDs, but they are also up to 100 times more expensive. [More]

df570721-3c4d-46f8-86d7-9681c14cf8be|0|.0

Posted in: Pharmaceutical News

Tags: Adalimumab, Arthritis, Biologics Drug / Agent, Etanercept, Infliximab, Medicare, Rheumatoid Arthritis

Researchers identify mechanism by which an anti-TNF therapy impairs host defense against tuberculosis

20. April 2009 23:06

The life of many individuals with inflammatory diseases such as rheumatoid arthritis has been dramatically improved by treatment with drugs that target the protein TNF, so called anti-TNF therapies. [More]

ffc39d9d-97f5-4ffa-bda5-0ba8887a0e65|0|.0

Posted in: Medical Research News

Tags: Arthritis, Inflammatory Disease, Infliximab, Rheumatoid Arthritis, TNF Blockers, Tuberculosis

Infliximab after intestinal resective surgery may help prevent post-op Crohn's disease recurrence

2. February 2009 12:29

The administration of infliximab after intestinal resective surgery was found to be effective at preventing endoscopic and histological recurrence of Crohn's disease, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute. [More]

bcb86359-e686-422c-9941-e8d6866d33ac|0|.0

Posted in: Drug Trial News

Tags: Biologics Drug / Agent, Crohn's Disease, Gastroenterology, Infliximab

Free!

Recent Comments

Twitter

Information

Infliximab News and Research

TNF therapy does not raise cancer risk in RA patients; overall cancer risk comparable to those not taking immunosuppressive drugs

New data from CIMZIA WELCOME trial to be presented at the ACG meeting

Report on the future market potential for monoclonal antibodies

New data on Phase 3 SIMPONI clinical trials for rheumatoid arthritis

Johnson & Johnson announces financial results for the third quarter of 2009

More studies needed to compare the efficacy of different biologic drugs for RA, say researchers

Mayo study reveals infliximab reduces the need for colectomy

Reportlinker's medical review criteria guidelines for managing care

Comprehensive and practical overview of psoriasis

Report on autoimmune disease therapeutics in worldwide markets

New report on the psoriasis market offered by Research and Markets

Golimumab shows promise for rheumatoid arthritis

Impact of Medicare Part D on access to and cost sharing for specialty biologic medications for beneficiaries with rheumatoid arthritis

Researchers identify mechanism by which an anti-TNF therapy impairs host defense against tuberculosis

Infliximab after intestinal resective surgery may help prevent post-op Crohn's disease recurrence

Recent Articles

Free!

Recent Comments

Twitter

Information

Infliximab News and Research

Medical News Cloud

Recent Articles